NYU Langone Health: Anti-Platelet Drug Class Does Not Increase Survival in Hospitalized COVID-19 Patients With Moderate Cases

Press/Media

Period16 Nov 2021

Media coverage

1

Media coverage

  • TitleNYU Langone Health: Anti-Platelet Drug Class Does Not Increase Survival in Hospitalized COVID-19 Patients With Moderate Cases
    Media name/outletTargeted News Service
    Country/TerritoryUnited States
    Date16/11/21
    PersonsJennifer Wilson